Oncology Central

Latest advances in the management of elderly patients with multiple myeloma


In the last few years many advances have been made in the understanding and treatment of multiple myeloma (MM). MM is a plasma cell neoplasm that accounts for approximately 10% of all hematologic malignancies, it is typical of the elderly, with a median age at diagnosis of 65 years [101].

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.